Pacific Biosciences of California, Inc. Business Acquisition, Pro Forma Revenue
Pacific Biosciences of California, Inc. (PACB) reported Business Acquisition, Pro Forma Revenue of $34.89 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2022-11-08
- Pacific Biosciences of California, Inc. business acquisition, pro forma revenue for the quarter ending 2021-09-30 was $34.89M, a 82.83% increase year-over-year.
- Pacific Biosciences of California, Inc. business acquisition, pro forma revenue for the quarter ending 2020-09-30 was $19.08M.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 9 month |
|---|---|---|
| 2021-09-30 | $34.89M 10-Q · filed 2022-11-08 | $94.49M 10-Q · filed 2021-11-05 |
| 2020-09-30 | $19.08M 10-Q · filed 2021-11-05 | $51.76M 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |